Year |
Citation |
Score |
2023 |
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, ... ... Woolley JD, et al. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Focus (American Psychiatric Publishing). 21: 315-328. PMID 37404971 DOI: 10.1176/appi.focus.23021011 |
0.496 |
|
2022 |
Khan AJ, Bradley E, O'Donovan A, Woolley J. Psilocybin for Trauma-Related Disorders. Current Topics in Behavioral Neurosciences. PMID 35711024 DOI: 10.1007/7854_2022_366 |
0.603 |
|
2022 |
Nishimi K, Borsari B, Tripp P, Jiha A, Dolsen EA, Woolley JD, Neylan TC, O'Donovan A. Prior trauma exposure, posttraumatic stress symptoms, and COVID-19 vaccine hesitancy. Journal of Psychiatric Research. 151: 399-404. PMID 35588548 DOI: 10.1016/j.jpsychires.2022.05.003 |
0.548 |
|
2022 |
Nishimi K, Borsari B, Marx BP, Tripp P, Woodward E, Rosen RC, Cohen BE, Maven D, Jiha A, Woolley JD, Neylan TC, O'Donovan A. Posttraumatic stress disorder symptoms associated with protective and risky behaviors for coronavirus disease 2019. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 41: 104-114. PMID 35238581 DOI: 10.1037/hea0001157 |
0.604 |
|
2022 |
Nishimi K, Borsari B, Marx BP, Rosen RC, Cohen BE, Woodward E, Maven D, Tripp P, Jiha A, Woolley JD, Neylan TC, O'Donovan A. Clusters of COVID-19 protective and risky behaviors and their associations with pandemic, socio-demographic, and mental health factors in the United States. Preventive Medicine Reports. 25: 101671. PMID 34926133 DOI: 10.1016/j.pmedr.2021.101671 |
0.555 |
|
2021 |
Stauffer CS, Morrison TE, Meinzer NK, Leung D, Buffington J, Sheh EG, Neylan TC, O'Donovan A, Woolley JD. Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial. Psychiatry Research. 308: 114340. PMID 34983010 DOI: 10.1016/j.psychres.2021.114340 |
0.622 |
|
2021 |
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, ... ... Woolley JD, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine. PMID 33972795 DOI: 10.1038/s41591-021-01336-3 |
0.493 |
|
2020 |
Niles AN, Woolley JD, Tripp P, Pesquita A, Vinogradov S, Neylan TC, O'Donovan A. Randomized Controlled Trial Testing Mobile-Based Attention-Bias Modification for Posttraumatic Stress Using Personalized Word Stimuli. Clinical Psychological Science : a Journal of the Association For Psychological Science. 8: 756-772. PMID 34414018 DOI: 10.1177/2167702620902119 |
0.596 |
|
2020 |
Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. Eclinicalmedicine. 27: 100538. PMID 33150319 DOI: 10.1016/j.eclinm.2020.100538 |
0.404 |
|
2020 |
Stauffer CS, Moschetto JM, McKernan S, Meinzer N, Chiang C, Rapier R, Hsiang E, Norona J, Borsari B, Woolley JD. Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial. Journal of Substance Abuse Treatment. 116: 108059. PMID 32741502 DOI: 10.1016/J.Jsat.2020.108059 |
0.392 |
|
2020 |
Flanagan JC, Mitchell JM, Baker NL, Woolley J, Wangelin B, Back SE, McQuaid JR, Neylan TC, Woolfe WR, Brady KT. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemporary Clinical Trials. 106074. PMID 32561468 DOI: 10.1016/J.Cct.2020.106074 |
0.55 |
|
2020 |
Ahmadian AJ, Lin JE, Neylan TC, Woolley JD, O'Donovan A, Cohen BE. Social Integration and Inflammation in Individuals with and without Posttraumatic Stress Disorder. Brain, Behavior, and Immunity. PMID 32534985 DOI: 10.1016/J.Bbi.2020.06.013 |
0.621 |
|
2020 |
Niles AN, Woolley JD, Tripp P, Pesquita A, Vinogradov S, Neylan TC, O’Donovan A. Randomized Controlled Trial Testing Mobile-Based Attention-Bias Modification for Posttraumatic Stress Using Personalized Word Stimuli Clinical Psychological Science. 8: 756-772. DOI: 10.1177/2167702620902119 |
0.364 |
|
2019 |
Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD. Effects of oxytocin administration on cue-induced craving in co-occurring alcohol use disorder and PTSD: a within-participant randomized clinical trial. Alcoholism, Clinical and Experimental Research. PMID 31610033 DOI: 10.1111/Acer.14217 |
0.638 |
|
2019 |
Abram SV, De Coster L, Roach BJ, Mueller BA, van Erp TGM, Calhoun VD, Preda A, Lim KO, Turner JA, Ford JM, Mathalon DH, Woolley JD. Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial. Schizophrenia Bulletin. PMID 31595302 DOI: 10.1093/Schbul/Sbz091 |
0.625 |
|
2019 |
Bradley ER, Seitz A, Niles AN, Rankin KP, Mathalon DH, O'Donovan A, Woolley JD. Oxytocin increases eye gaze in schizophrenia. Schizophrenia Research. PMID 31416746 DOI: 10.1016/J.Schres.2019.07.039 |
0.668 |
|
2019 |
De Coster L, Lin L, Mathalon DH, Woolley JD. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31103018 DOI: 10.1038/S41386-019-0417-5 |
0.536 |
|
2019 |
Bradley ER, Brustkern J, De Coster L, van den Bos W, McClure SM, Seitz A, Woolley JD. Victory is its own reward: oxytocin increases costly competitive behavior in schizophrenia. Psychological Medicine. 1-9. PMID 30944045 DOI: 10.1017/S0033291719000552 |
0.352 |
|
2019 |
Stauffer CS, Moschetto JM, McKernan SM, Hsiang E, Borsari B, Woolley JD. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial. Trials. 20: 145. PMID 30791944 DOI: 10.1186/S13063-019-3225-7 |
0.352 |
|
2019 |
Anderson B, Danforth A, Daroff R, Stauffer C, Dilley J, Mitchell J, Woolley J. T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.460 |
0.432 |
|
2018 |
Fulford D, Treadway M, Woolley J. Social motivation in schizophrenia: The impact of oxytocin on vigor in the context of social and nonsocial reinforcement. Journal of Abnormal Psychology. 127: 116-128. PMID 29369669 DOI: 10.1037/Abn0000320 |
0.386 |
|
2018 |
Stauffer C, Morrison T, Leung D, Wen J, Batki S, Neylan T, O'Donovan A, Woolley J. S16. The Effects of Oxytocin on Comorbid Symptoms of Posttraumatic Stress Disorder (PTSD) and Alcohol Use Disorder (AUD): An Examination of Alcohol Craving, Social Perception, and Fear Potentiated Startle Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.907 |
0.638 |
|
2017 |
Human LJ, Woolley JD, Mendes WB. Effects of Oxytocin Administration on Receiving Help. Emotion (Washington, D.C.). PMID 29172621 DOI: 10.1037/Emo0000369 |
0.315 |
|
2017 |
Bradley ER, Woolley JD. Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward. Neuroscience and Biobehavioral Reviews. PMID 28506922 DOI: 10.1016/j.neubiorev.2017.05.007 |
0.381 |
|
2017 |
Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B, Kermott A, Woolley J, Vinogradov S. Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report. Psychiatric Rehabilitation Journal. 40: 21-32. PMID 28368179 DOI: 10.1037/Prj0000244 |
0.315 |
|
2017 |
Human LJ, Thorson KR, Woolley JD, Mendes WB. Combining oxytocin administration and positive emotion inductions: Examining social perception and analytical performance. Hormones and Behavior. 90: 120-128. PMID 28324706 DOI: 10.1016/J.Yhbeh.2017.03.002 |
0.301 |
|
2017 |
Woolley JD, Chuang B, Fussell C, Scherer S, Biagianti B, Fulford D, Mathalon DH, Vinogradov S. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls. Psychological Medicine. 1-12. PMID 28091349 DOI: 10.1017/S0033291716003433 |
0.534 |
|
2016 |
Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD. A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction Research & Theory. 24: 490-498. PMID 28503120 DOI: 10.3109/16066359.2016.1173682 |
0.303 |
|
2016 |
Mitchell JM, Arcuni PA, Weinstein D, Woolley JD. Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder. Journal of Addiction Medicine. PMID 27159342 DOI: 10.1097/ADM.0000000000000213 |
0.484 |
|
2016 |
Chuang B, Campbell S, Dalton C, Mathalon D, Vinogradov S, Leitman D, Woolley J. The effects of oxytocin on emotional verbal prosodyin individuals with Schizophrenia and healthy controls F1000research. 5. DOI: 10.7490/F1000Research.1112136.1 |
0.488 |
|
2015 |
Quintana DS, Woolley JD. Intranasal Oxytocin Mechanisms Can Be Better Understood, but Its Effects on Social Cognition and Behavior Are Not to Be Sniffed At. Biological Psychiatry. PMID 26212900 DOI: 10.1016/j.biopsych.2015.06.021 |
0.31 |
|
2015 |
Woolley JD, Lam O, Chuang B, Ford JM, Mathalon DH, Vinogradov S. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia. Psychoneuroendocrinology. 53: 217-22. PMID 25637811 DOI: 10.1016/J.Psyneuen.2014.12.018 |
0.615 |
|
2015 |
Mitchell J, Weinstein D, Arcuni P, Laxamana J, Woolley J. The effects of intranasal oxytocin on social cognition, implicit preferences and craving in alcoholics Drug and Alcohol Dependence. 146: e42. DOI: 10.1016/J.DRUGALCDEP.2014.09.485 |
0.503 |
|
2014 |
Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S. Corrigendum to "Oxytocin administration enhances controlled social cognition in patients with schizophrenia" [Psychoneuroendocrinology 47 (2014) 116-125]. Psychoneuroendocrinology. 52: 13. PMID 25497479 DOI: 10.1016/J.Psyneuen.2014.11.001 |
0.625 |
|
2014 |
Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology. 47: 116-25. PMID 25001961 DOI: 10.1016/J.Psyneuen.2014.04.024 |
0.672 |
|
2014 |
Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, Rahaman N, Joyce J, Hinton M, Johnson S, Young AH. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychological Medicine. 44: 499-506. PMID 23701858 DOI: 10.1017/S0033291713000883 |
0.319 |
|
2007 |
Woolley JD, Lee BS, Kim B, Fields HL. Opposing effects of intra-nucleus accumbens mu and kappa opioid agonists on sensory specific satiety. Neuroscience. 146: 1445-52. PMID 17445988 DOI: 10.1016/j.neuroscience.2007.03.012 |
0.511 |
|
2007 |
Woolley JD, Lee BS, Taha SA, Fields HL. Nucleus accumbens opioid signaling conditions short-term flavor preferences. Neuroscience. 146: 19-30. PMID 17320293 DOI: 10.1016/j.neuroscience.2007.01.005 |
0.645 |
|
2006 |
Woolley JD, Lee BS, Fields HL. Nucleus accumbens opioids regulate flavor-based preferences in food consumption. Neuroscience. 143: 309-17. PMID 17049180 DOI: 10.1016/j.neuroscience.2006.06.067 |
0.506 |
|
2006 |
Taha SA, Norsted E, Lee LS, Lang PD, Lee BS, Woolley JD, Fields HL. Endogenous opioids encode relative taste preference. The European Journal of Neuroscience. 24: 1220-6. PMID 16925586 DOI: 10.1111/j.1460-9568.2006.04987.x |
0.64 |
|
Show low-probability matches. |